OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2021
(5)
2023
(2)
2020
(1)
2019
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.
Not available
S-EPMC5978471
|
biostudies-literature
Cite
In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit.
Not available
S-EPMC7867783
|
biostudies-literature
Cite
Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8
+
T cells compared with women with BRCA wild-type disease during the early disease course.
Not available
S-EPMC6732977
|
biostudies-literature
Cite
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.
Not available
S-EPMC8611843
|
biostudies-literature
Cite
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.
Not available
S-EPMC9972172
|
biostudies-literature
Cite
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia.
Not available
S-EPMC8915247
|
biostudies-literature
Cite
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
Not available
S-EPMC9825728
|
biostudies-literature
Cite
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
Not available
S-EPMC8265825
|
biostudies-literature
Cite
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Not available
S-EPMC8236112
|
biostudies-literature
Cite
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.
Not available
S-EPMC8048383
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets